{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T06:12:44Z","timestamp":1791094364832,"version":"4.1.0"},"reference-count":26,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2013,2,7]],"date-time":"2013-02-07T00:00:00Z","timestamp":1360195200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0055709","type":"journal-article","created":{"date-parts":[[2013,2,7]],"date-time":"2013-02-07T17:26:07Z","timestamp":1360257967000},"page":"e55709","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":33,"title":["Candidate Sequence Variants and Fetal Hemoglobin in Children with Sickle Cell Disease Treated with Hydroxyurea"],"prefix":"10.1371","volume":"8","author":[{"given":"Nancy S.","family":"Green","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine L.","family":"Ender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farzana","family":"Pashankar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Driscoll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia J.","family":"Giardina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig A.","family":"Mullen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorraine N.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepa","family":"Manwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Crotty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergey","family":"Kisselev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen A.","family":"Neville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn","family":"Hoppe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Barral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,2,7]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood.V69.1.1.1","article-title":"Subunit assembly of hemoglobin: an important determinant of hematologic phenotype","volume":"69","author":"HF Bunn","year":"1987","journal-title":"Blood"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1182\/blood.V63.4.921.921","article-title":"Is there a threshold level of fetal hemoglobin that ameliorates morbidity in sickle cell anemia?","volume":"63","author":"DR Powars","year":"1984","journal-title":"Blood"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1056\/NEJMct0708272","article-title":"Hydroxyurea for the treatment of sickle cell anemia","volume":"358","author":"OS Platt","year":"2008","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/ajh.10264","article-title":"Concordant fetal hemoglobin response to hydroxyurea in siblings with sickle cell disease","volume":"72","author":"MH Steinberg","year":"2003","journal-title":"Am J Hematol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"R216","DOI":"10.1093\/hmg\/ddp401","article-title":"Control of fetal hemoglobin: new insights emerging from genomics and clinical implications","volume":"18","author":"SL Thein","year":"2009","journal-title":"Hum Mol Genet"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1038\/ng.707","article-title":"Fine-mapping at three loci known to affect fetal hemoglobin levels explains additional genetic variation","volume":"42","author":"G Galarneau","year":"2010","journal-title":"Nat Genet"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"11869","DOI":"10.1073\/pnas.0804799105","article-title":"DNA polymorphisms at the BCL11A, HBS1L-MYB, and beta-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease","volume":"105","author":"G Lettre","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1182\/blood-2010-08-302703","article-title":"Genetics of fetal hemoglobin in Tanzanian and British patients with sickle cell anemia","volume":"117","author":"J Makani","year":"2011","journal-title":"Blood"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/ajh.21048","article-title":"Fetal hemoglobin in sickle cell anemia: Bayesian modeling of genetic associations","volume":"83","author":"P Sebastiani","year":"2008","journal-title":"Am J Hematol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/jhg.2011.12","article-title":"Genome-wide association study identifies genetic variants influencing F-cell levels in sickle-cell patients","volume":"56","author":"P Bhatnagar","year":"2011","journal-title":"J Hum Genet"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.bcmd.2008.06.007","article-title":"BCL11A is a major HbF quantitative trait locus in three different populations with beta-hemoglobinopathies","volume":"41","author":"AE Sedgewick","year":"2008","journal-title":"Blood Cells Mol Dis"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1182\/blood-2012-06-432849","article-title":"Meta-analysis of 2040 sickle cell anemia patients: BCL11A and HBS1L-MYB are the major modifiers of HbF in African Americans","volume":"120","author":"HT Bae","year":"2012","journal-title":"Blood"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/sj.tpj.6500433","article-title":"Fetal hemoglobin in sickle cell anemia: genetic determinants of response to hydroxyurea","volume":"7","author":"Q Ma","year":"2007","journal-title":"Pharmacogenomics J"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1182\/blood-2009-08-239517","article-title":"Fetal hemoglobin in sickle cell anemia: genome-wide association studies suggest a regulatory region in the 5\u2032 olfactory receptor gene cluster","volume":"115","author":"N Solovieff","year":"2010","journal-title":"Blood"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/pbc.22643","article-title":"Expression patterns of fetal hemoglobin in sickle cell erythrocytes are both patient- and treatment-specific during childhood","volume":"56","author":"ER Meier","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1182\/blood.V89.3.1078","article-title":"Fetal hemoglobin in sickle cell anemia: determinants of response to hydroxyurea. Multicenter Study of Hydroxyurea","volume":"89","author":"MH Steinberg","year":"1997","journal-title":"Blood"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/pbc.22754","article-title":"Genetic modifiers of HbF and response to hydroxyurea in sickle cell disease","volume":"56","author":"NS Green","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1182\/blood.V99.1.10","article-title":"Predictors of fetal hemoglobin response in children with sickle cell anemia receiving hydroxyurea therapy","volume":"99","author":"RE Ware","year":"2002","journal-title":"Blood"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"4985","DOI":"10.1182\/blood-2011-07-364190","article-title":"Pharmacokinetics, pharmacodynamics, and pharmacogenetics of hydroxyurea treatment for children with sickle cell anemia","volume":"118","author":"RE Ware","year":"2011","journal-title":"Blood"},{"key":"ref20","first-page":"15","article-title":"Mechanism of action of hydroxyurea in the management of sickle cell anemia in adults","volume":"34","author":"S Charache","year":"1997","journal-title":"Semin Hematol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1365-2141.2008.07045.x","article-title":"Fetal haemoglobin response to hydroxycarbamide treatment and sar1a promoter polymorphisms in sickle cell anaemia","volume":"141","author":"C Kumkhaek","year":"2008","journal-title":"Br J Haematol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1182\/blood-2003-07-2475","article-title":"Sustained long-term hematologic efficacy of hydroxyurea at maximum tolerated dose in children with sickle cell disease","volume":"103","author":"SA Zimmerman","year":"2004","journal-title":"Blood"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/ajh.2830440214","article-title":"Senegal haplotype is associated with higher HbF than Benin and Cameroon haplotypes in African children with sickle cell anemia","volume":"44","author":"NS Green","year":"1993","journal-title":"Am J Hematol"},{"key":"ref24","unstructured":"Gauderman WJ, Morrison JM (2006) QUANTO 1.1: A computer program for power and sample size calculations for genetic-epidemiology studies."},{"key":"ref25","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1086\/519795","article-title":"PLINK: a tool set for whole-genome association and population-based linkage analyses","volume":"81","author":"S Purcell","year":"2007","journal-title":"Am J Hum Genet"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1097\/MPH.0b013e31822dcc21","article-title":"Fetal hemoglobin levels in African American and Hispanic children with sickle cell disease at baseline and in response to hydroxyurea","volume":"33","author":"KL Ender","year":"2011","journal-title":"J Pediatr Hematol Oncol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0055709","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,21]],"date-time":"2020-07-21T22:03:15Z","timestamp":1595368995000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0055709"}},"subtitle":[],"editor":[{"given":"Dimas Tadeu","family":"Covas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,2,7]]},"references-count":26,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2013,2,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0055709","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,7]]}}}